Other Useful Information
>
Letters to Trade
Letters to Trade
Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate in the United Kingdom (Letter to Healthcare Professionals)
Attachment:
Fluoroquinolone antibiotics
Related Information:
Australia: More prominent warnings about serious side effects for fluoroquinolon...
Posted 2025-03-07
The United Kingdom: Fluoroquinolone antibiotics: must now only be prescribed whe...
Posted 2024-01-23
The United Kingdom: Fluoroquinolone antibiotics: reminder of the risk of disabli...
Posted 2023-08-31
European Union: Fluoroquinolone antibiotics: reminder of measures to reduce the ...
Posted 2023-05-13
Australia: Update: fluoroquinolone antibiotics and adverse events
Posted 2020-02-27
The United Kingdom: Fluoroquinolone antibiotics: new restrictions and precaution...
Posted 2019-03-22
European Union : Disabling and potentially permanent side effects lead to suspen...
Posted 2018-11-17
Fluoroquinolone and quinolone antibiotics: PRAC recommends restrictions on use (...
Posted 2018-10-08
European Union: Fluoroquinolone and quinolone antibiotics: PRAC recommends restr...
Posted 2018-10-06
China: Announcement by China Food and Drug Administration (CFDA) on amendment of...
Posted 2017-07-06
European Union: European Medicines Agency (EMA) reviews persistence of side effe...
Posted 2017-02-11
Canada: FLUOROQUINOLONES - Risk of disabling and persistent serious adverse reac...
Posted 2017-01-24
The United States: FDA Drug Safety Communication: FDA updates warnings for oral ...
Posted 2016-07-27
The United States: FDA Drug Safety Communication: FDA advises restricting fluoro...
Posted 2016-05-13
Fluoroquinolones: restricting use for certain uncomplicated infections (Letter t...
Posted 2016-05-13